Ocular Therapeutix Inc. (OCUL)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
8.11
0.25 (3.18%)
At close: Jan 15, 2025, 11:14 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
Revenue | 58.44M | 51.49M | 43.52M | 17.40M | 4.23M | 1.99M | 1.92M | 1.89M | 1.75M | 772.00K | n/a | 10.00K |
Cost of Revenue | 5.28M | 4.54M | 4.41M | 2.08M | 2.33M | 465.00K | 457.00K | 443.00K | 319.00K | 91.00K | 10.52M | 7.00K |
Gross Profit | 53.16M | 46.95M | 39.12M | 15.32M | 1.90M | 1.52M | 1.47M | 1.44M | 1.43M | 681.00K | -10.52M | 3.00K |
Operating Income | -82.38M | -78.65M | -78.04M | -62.85M | -85.80M | -59.12M | -61.92M | -43.33M | -38.20M | -27.09M | -12.90M | -13.67M |
Interest Income | 3.98M | 798.00K | 33.00K | 168.00K | 1.23M | 879.00K | 424.00K | 304.00K | 166.00K | 7.00K | 13.00K | 4.00K |
Pretax Income | -80.74M | -71.04M | -6.55M | -155.64M | -86.37M | -59.98M | -63.39M | -44.70M | -39.75M | -28.65M | -13.32M | -14.09M |
Net Income | -80.74M | -63.42M | -10.80M | -159.63M | -89.94M | -57.69M | -63.39M | -44.70M | -39.75M | -28.65M | -13.32M | -14.09M |
Selling & General & Admin | 74.49M | 72.15M | 67.07M | 49.47M | 46.61M | 23.73M | 32.51M | 17.70M | 13.02M | 8.89M | 2.39M | 2.13M |
Research & Development | 61.05M | 53.46M | 50.08M | 28.69M | 41.09M | 36.91M | 30.88M | 27.07M | 26.61M | 18.88M | 10.52M | 11.54M |
Other Expenses | n/a | -1K | 1K | n/a | -8.00K | n/a | 5.00K | -1K | 7.00K | -442.00K | 14.00K | -49.00K |
Operating Expenses | 135.54M | 125.61M | 117.15M | 78.17M | 87.70M | 60.64M | 63.39M | 44.77M | 39.63M | 27.77M | 12.90M | 13.67M |
Interest Expense | 11.34M | 7.02M | 6.67M | 6.77M | 6.10M | 1.74M | 1.89M | 1.68M | 1.72M | 1.12M | 441.00K | 377.00K |
Selling & Marketing Expenses | 40.55M | 39.92M | 35.19M | 26.61M | 24.49M | 4.94M | 17.00M | 6.70M | 3.85M | 1.98M | 625.00K | 657.00K |
Cost & Expenses | 140.82M | 130.15M | 121.56M | 80.25M | 90.03M | 61.11M | 63.85M | 45.21M | 39.95M | 27.87M | 12.90M | 13.68M |
Income Tax | n/a | -7.62M | 4.25M | 4.00M | 3.56M | -2.29M | 272.00K | 798.00K | 977.00K | 130.00K | 455.00K | 328.00K |
Shares Outstanding (Basic) | 79.83M | 76.88M | 76.39M | 60.75M | 45.27M | 38.12M | 28.82M | 24.82M | 23.24M | 10.65M | 2.95M | 2.95M |
Shares Outstanding (Diluted) | 85.60M | 76.88M | 82.16M | 60.75M | 45.27M | 38.12M | 28.82M | 24.82M | 23.24M | 10.65M | 2.95M | 2.95M |
EPS (Basic) | -1.09 | -0.83 | -0.14 | -2.63 | -1.99 | -1.51 | -2.2 | -1.8 | -1.71 | -2.69 | -4.51 | -4.77 |
EPS (Diluted) | -1.02 | -0.83 | -0.13 | -2.63 | -1.99 | -1.51 | -2.2 | -1.8 | -1.71 | -2.69 | -4.51 | -4.77 |
EBITDA | -66.42M | -61.91M | -75.62M | -146.09M | -77.74M | -55.95M | -59.87M | -42.14M | -37.27M | -26.98M | -12.50M | -13.31M |
Depreciation & Amortization | 2.98M | 2.11M | 2.42M | 2.77M | 2.53M | 2.29M | 1.63M | 881.00K | 754.00K | 547.00K | 404.00K | 404.00K |